Answers are grounded in this paper and cite their sources.
This analysis highlights TNM staging improvements, using imaging methods that may enhance treatment and prognosis in malignant pleural mesothelioma.
Malignant pleural mesothelioma (PM) is the most common primary tumour of the pleura. Accurate staging is essential for treatment selection and prognostication. The 9th edition of the TNM classification introduces validated, imaging-based updates to tumour (T), node (N), and metastasis (M) staging. This article explores the scientific rationale and clinical utility of TNM 9, with a focus on imaging techniques, automated tumour volume assessment, and future developments in imaging and artificial intelligence.
No takes yet. Share an insight, caveat, or question.
Cheng Xie (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: